ImmuCell Corporation (ICCC)
Total Valuation
ImmuCell has a market cap or net worth of $41.00 million. The enterprise value is $55.70 million.
Market Cap | 41.00M |
Enterprise Value | 55.70M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
Earnings Date | May 9, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ImmuCell has 7.75 million shares outstanding.
Shares Outstanding | 7.75M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 28.25% |
Owned by Institutions (%) | 13.50% |
Float | 5.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.52 |
Forward PS | n/a |
PB Ratio | 1.58 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 3.42 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.64.
Current Ratio | 3.59 |
Quick Ratio | 1.16 |
Debt / Equity | 0.64 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.60% and return on invested capital (ROIC) is -14.94%.
Return on Equity (ROE) | -22.60% |
Return on Assets (ROA) | -14.30% |
Return on Capital (ROIC) | -14.94% |
Revenue Per Employee | $226,203 |
Profits Per Employee | -$87,537 |
Employee Count | 72 |
Asset Turnover | 0.37 |
Inventory Turnover | 2.00 |
Taxes
In the past 12 months, ImmuCell has paid $4,789 in taxes.
Income Tax | 4,789 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.07% in the last 52 weeks. The beta is 0.59, so ImmuCell's price volatility has been lower than the market average.
Beta (1Y) | 0.59 |
52-Week Price Change | +9.07% |
50-Day Moving Average | 5.19 |
200-Day Moving Average | 5.07 |
Relative Strength Index (RSI) | 55.70 |
Average Volume (30 Days) | 7,332 |
Short Selling Information
The latest short interest is 6,384, so 0.08% of the outstanding shares have been sold short.
Short Interest | 6,384 |
Short Previous Month | 6,316 |
Short % of Shares Out | 0.08% |
Short % of Float | 0.12% |
Short Ratio (days to cover) | 0.84 |
Income Statement
In the last 12 months, ImmuCell had revenue of $16.29 million and -$6.30 million in losses. Loss per share was -$0.81.
Revenue | 16.29M |
Gross Profit | 3.60M |
Operating Income | -6.38M |
Pretax Income | -6.30M |
Net Income | -6.30M |
EBITDA | -3.65M |
EBIT | -6.30M |
Loss Per Share | -$0.81 |
Balance Sheet
The company has $1.99 million in cash and $16.68 million in debt, giving a net cash position of -$14.69 million or -$1.90 per share.
Cash & Cash Equivalents | 1.99M |
Total Debt | 16.68M |
Net Cash | -14.69M |
Net Cash Per Share | -$1.90 |
Equity / Book Value | 26.01M |
Book Value Per Share | 3.36 |
Working Capital | 8.63M |
Cash Flow
In the last 12 months, operating cash flow was -$5.25 million and capital expenditures -$3.30 million, giving a free cash flow of -$8.55 million.
Operating Cash Flow | -5.25M |
Capital Expenditures | -3.30M |
Free Cash Flow | -8.55M |
FCF Per Share | -$1.10 |
Margins
Gross margin is 22.13%, with operating and profit margins of -39.16% and -38.70%.
Gross Margin | 22.13% |
Operating Margin | -39.16% |
Pretax Margin | -38.67% |
Profit Margin | -38.70% |
EBITDA Margin | -22.42% |
EBIT Margin | -38.67% |
FCF Margin | -52.48% |
Dividends & Yields
ImmuCell does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -15.37% |
FCF Yield | -20.85% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on July 25, 1990. It was a reverse split with a ratio of 1:100.
Last Split Date | Jul 25, 1990 |
Split Type | Reverse |
Split Ratio | 1:100 |
Scores
ImmuCell has an Altman Z-Score of 1.12 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.12 |
Piotroski F-Score | 1 |